- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01796639
Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China (REACH)
The primary objective of this study is to evaluate graft survival and recipient survival among kidney transplant recipients in China, and also to analyze possible factors related to patient and graft survival.
The secondary objective is to evaluate several secondary outcomes among kidney transplant recipients, such as average creatinine value, acute rejection episodes, NODM, incidence of BKV infection etc. At the same time analyze possible impact factors related to these secondary outcomes.
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
Renal transplantation is the choice for patients with end-stage renal disease. In the past two decades, progress in surgical procedure, medical care, and immunosuppression have significantly improved the short-term results of organ transplantation. Nevertheless, grafts continue to fail over time, these improvements in immunosuppression and reduced incidence of acute rejection episodes have had only minimal effects on chronic allograft dysfunction and late graft loss. Long-term patient's death and graft failure are the main limitations for a better performance of renal transplant programs.
Multiple factors have been shown to affect the outcome of renal transplantation. These include demographic characteristics such as race and ethnicity, pretransplantation dialysis course, the timing of the transplantation,and the patients' co morbidities. Patient response to the transplantation procedure (e.g., delayed graft function, acute rejection, and acute tubular necrosis) is strongly associated with the long-term prognosis. In the last decade, with the increase of immunosuppressive agents in our therapeutic arsenal, several attempts have been made to improve graft performance. However, the majority of trials aiming to avoid calcineurin inhibitor (CNI)-related nephrotoxicity only reported short-term data. Also, and because of the lack of assessment of the role of the different ethiopathogenic factors that lead to graft damage, just avoiding CNI-related nephrotoxicity may be an oversimplification of the problem in the prevention of graft attrition.
There are many studies which have evaluated the long-term outcomes of graft and patient survival and have analyzed multiple relative factors. Unfortunately, such data in Chinese population are lacking. Meanwhile, the situation in China is somewhat different with others, such as race, the dosage of immunosuppressant and so on. A better characterization of the weight of immune and non-immune factors responsible for graft damage may help us to improve the outcomes in transplant recipients. Studies derived from well-designed and well-performed patient registries can provide a real world view of clinical practice, patient outcomes, safety, and comparative effectiveness and cost effectiveness. The goal of this project is to analyze retrospective data collected by disease registry, then to evaluate the graft and recipient outcomes of kidney transplants and relative impact factors.
Tipo di studio
Iscrizione (Effettivo)
Contatti e Sedi
Luoghi di studio
-
-
Beijing
-
Beijing, Beijing, Cina, 100034
- Peking University First Hospital
-
Beijing, Beijing, Cina, 100853
- Chinese PLA General Hospital
-
Beijing, Beijing, Cina, 100000
- The 309th Hospital of Chinese People's Liberation Army
-
Beijing, Beijing, Cina, 100020
- Beijing Chaoyang Hospital
-
Beijing, Beijing, Cina, 100050
- Beijing Friendship Hospital
-
-
Fujian
-
Fuzhou, Fujian, Cina, 350025
- Fuzhou General hospital of Nanjing Military Command
-
-
Guangdong
-
Guangzhou, Guangdong, Cina, 510080
- The First Affiliated Hospital Sun Yat-Sen University
-
Guangzhou, Guangdong, Cina, 510599
- Nanfang Hospital
-
-
Henan
-
Zhengzhou, Henan, Cina, 450052
- The First Affiliated Hospital of Zhengzhou University
-
-
Hubei
-
Wuhan, Hubei, Cina, 430030
- Tongji Hospital
-
-
Hunan
-
Changsha, Hunan, Cina, 410000
- The second Xiangya Hospital of Central South University
-
-
Liaoning
-
Shenyang, Liaoning, Cina
- Shenyang Military General Hospital
-
-
Shandong
-
Jinan, Shandong, Cina, 250000
- Jinan Military General Hospital
-
-
Shanghai
-
Shanghai, Shanghai, Cina, 200032
- Zhongshan Hospital Fudan University
-
Shanghai, Shanghai, Cina, 200080
- Shanghai First People's Hospital
-
-
Shanxi
-
Xian, Shanxi, Cina, 710061
- First Affiliated Hospital Of Medical College of Xian Jiaotong University
-
-
Sichuan
-
Chengdu, Sichuan, Cina, 610041
- West China Hospital,Sichuan University
-
-
Zhejiang
-
Hangzhou, Zhejiang, Cina, 310003
- The First Affiliated Hospital, Zhejiang University
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- Kidney transplant recipients
- Received a transplant from Jan 1,1995 to Dec 31, 2007, only including those with living donor grafts
- Age: 18-75 years
Exclusion Criteria:
- Multiple-organ transplant recipients
- Patients records with missing information in 12 months post-transplantation
- Patients who did not have the information regarding their maintenance immunosuppressive therapy
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Modelli osservazionali: Coorte
- Prospettive temporali: Retrospettiva
Coorti e interventi
Gruppo / Coorte |
---|
kidney transplantation patients with living-donor grafts
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Graft survival
Lasso di tempo: 5-year
|
Graft survival, measured as the time between kidney transplant and the failure of the graft.
|
5-year
|
Recipient survival
Lasso di tempo: 5-year
|
measured as the time between the most recent kidney transplant and the patient's death.
Graft outcome was censored at the earliest of the following events and was analyzed as days to graft failure or censor: loss to follow-up, patient death.
|
5-year
|
Misure di risultato secondarie
Misura del risultato |
Lasso di tempo |
---|---|
Average creatinine value
Lasso di tempo: 5 years
|
5 years
|
The rate of acute rejection episodes
Lasso di tempo: 5 years
|
5 years
|
The incidence of BPAR and its severity
Lasso di tempo: 5 years
|
5 years
|
The incidence of NODM
Lasso di tempo: 5 years
|
5 years
|
The incidence of infection
Lasso di tempo: 5 years
|
5 years
|
The incidence of biopsy proven CNIs nephrotoxicity
Lasso di tempo: 5 years
|
5 years
|
The rate of posttransplantation malignancies
Lasso di tempo: 5 years
|
5 years
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
- COLO400ACN02
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
prodotto fabbricato ed esportato dagli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .